Post-COVID-19, colonoscopy and FIT usage declined, while stool DNA testing increased among privately insured adults. Screening preferences varied by sex, socioeconomic status, and metropolitan versus ...
Fitgurú on MSN
The blood test that may detect cancer before symptoms appear and when you should ask about it
Many cancers, including pancreatic, ovarian, esophageal, and certain liver cancers, are often diagnosed at advanced stages ...
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program We distributed a 21-item survey on cancer screening ...
Adherence with the multitarget stool DNA test for colorectal cancer screening in rural southeastern Kentucky. This is an ASCO Meeting Abstract from the 2022 ASCO Gastrointestinal Cancers Symposium.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results